Life quality and related factors of bladder cancer patients after endoscopic transurethral surgery at Vietnam National Cancer Hospital in 2023
Main Article Content
Abstract
Bladder cancer, a common cancer, especially in men and the elderly, has high risk of recurrence and greatly affects the patient's quality of life (QoL). Transurethral resection of bladder tumor (TURBT) is a mainly treatment method for non muscle invasive bladder cancer (NMIBC). This study used 2 questionaires, EORTC QLQ-C30 and EORTC QLQ-NMIBC24, to evaluate the health related to quality of life (HRQoL) in 92 bladder cancer patients and analyse the relationship between HRQoL and other factors such as sociological and clinical characteristics. The results showed that the common QoL average score is 58.06 ± 15.84. Age, recurrence, urinary symptoms and financing difficulties significantly affected the patient's QoL. Conclusion: The quality of life score of NMIBC patients after TURBT was moderate (58.06 ± 15.84) and influenced by age, tumor recurrence, urinary symptoms, financial burden, and anxiety about the future. To improve the quality of life of this patient group, comprehensive multidisciplinary care strategies on medical, psychological, social, and financial support are very important.
Article Details
Keywords
Bladder cancer, NMIBC, TURBT, QoL, EORTC QLQ-C30 and EORTC QLQ-NMIBC24
References
2. Burger M, Catto JWF, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234-241. doi:10.1016/j.eururo.2012.07.033
3. Babjuk M, Burger M, Compérat EM, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol. 2019;76(5):639-657. doi:10.1016/j.eururo.2019.08.016
4. Nguyễn Bá Đức, và cs. Bệnh viện K - 50 năm xây dựng và phát triển (1969-2019).
5. Blazeby JM, Hall E, Aaronson NK, et al. Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. Eur Urol. 2014;66(6):1148-1156. doi:10.1016/j.eururo.2014.02.034
6. Brussels. Scoring Manual. EORTC – Quality of Life. October 17, 2017. https://qol.eortc.org/manual/scoring-manual/
7. Ripping TM, Westhoff E, Aaronson NK, et al. Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer. J Patient Rep Outcomes. 2021;5(1):96. doi:10.1186/s41687-021-00372-4
8. Catto JWF, Downing A, Mason S, et al. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes. Eur Urol. 2021;79(5):621-632. doi:10.1016/j.eururo.2021.01.032
9. Bùi Vũ Bình, Đỗ Thị Ánh, Dương Tiến Đỉnh, và cs. Khảo sát chất lượng cuộc sống của bệnh nhân ung thư và một số yếu tố ảnh hưởng tại Bệnh viện Đại học Y Hà Nội năm 2015. Hội nghị khoa học Điều dưỡng. Bệnh viện Quân y 103. October 9, 2020. https://benhvien103.vn/khao-sat-chat-luong-cuoc-song-cua-benh-nhan-ung-thu-va-mot-so-yeu-to-anh-huong-tai-benh-vien-dai-hoc-y-ha-noi-nam-2015/
10. Park J, Choi YD, Lee K, et al. Quality of life patterns and its association with predictors among non-muscle invasive bladder cancer survivors: A latent profile analysis. Asia Pac J Oncol Nurs. 2022;9(6):100063. doi:10.1016/j.apjon.2022.04.002
11. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
12. Jung A, Nielsen ME, Crandell JL, et al. Health-related quality of life among non-muscle-invasive bladder cancer survivors: a population-based study. BJU Int. 2020;125(1):38-48. doi:10.1111/bju.14888
13. Park J, Shin DW, Kim TH, et al. Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24. Cancer Res Treat. 2018;50(1):40-49. doi:10.4143/crt.2016.594
14. Turner B. Nursing care and treatment of patients with bladder cancer. Nurs Stand. 2009;23(37):47-56; quiz 58. doi:10.7748/ns2009.05.23.37.47.c6973
15. Rammant E, Fox L, Beyer K, et al. The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review. Qual Life Res. 2023;32(8):2127-2135. doi:10.1007/s11136-022-03335-4
16. Cocks K, Wells JR, Johnson C, et al. Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. Eur J Cancer. 2023;178:128-138. doi:10.1016/j.ejca.2022.10.026